- Neoleukin Therapeutics (NASDAQ:NLTX) on Friday announced a reverse stock split of the company’s outstanding shares of common stock at a ratio of 1-for-5.
- The reverse stock split is part of Neoleukin’s plan to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share.
- Neoleukin’s common stock will begin trading on a post-reverse stock split basis on September 25, under Neoleukin’s existing trading symbol "NLTX".
- NLTX is -0.92% to $0.6925.
- Source: Press Release
Recommended For You
More Trending News
See More »